Devarbhavi H, Dierkhising R, Kremers WK, et al. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality[J]. Am J Gastroenterol,2010,105(11): 2396-404. (PMID:20648003)
[5]
Shakya R, Rao BS, Shrestha B. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors[J]. Ann Pharmacother,2004,38(6): 1074-9. (PMID:15122004)
[6]
Wong WM, Wu PC, Yuen MF, et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection[J]. Hepatology,2000, 31(1): 201-6. (PMID:10613746)
[7]
Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A[J]. Biochem Pharmacol,1992, 44(2): 275-83. (PMID: 1642641)
Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy[J]. Am J Respir Crit Care Med,2006,174(8): 935-52. (PMID: 17021358)
